In addition, Xu et al. also demonstrated that PESV is effective in recovering immunosurveillance and intervening immune escape of lung cancer by decreasing the level of VEGF (a marker of endothelial dysfunction), TGF-β1 (profibrotic factor), and IL-10 [27]. The gene discussed is TGFB1; the disease is lung carcinoma.